抖圈官网

leo_gymc
Home-Hua Medicine
gx_imgmc
l_a1_xxjt
SCROLL
l_a1_sgdqq
gx_imgmc
About Hua Medicine

Collaborative Innovation

Hua Medicine is an innovative drug development and commercialization company based in Shanghai, China. Hua Medicine focused on developing novel therapies for patients worldwide with unmet medical needs. Based on global resources, Hua Medicine teams up with global high-caliber people to develop breakthrough technologies and products, which contribute a global innovation in diabetes care.

2011
Established
25%
R&D Team
100+
Clinical Center
l_a1_two_xx
2011
Established
25%
R&D Team
100+
Clinical Center
l_a1_tbf l_a1_tzt
Scientific R&D

Research Area

Glucokinase Activator(GKA) --- Dorzagliatin(HMS5552)is a first-in-class oral drug for the treatment of type 2 diabetes that under developed by Hua Medicine. Dorzagliatin has brand new mechanism and structure.
mGluR5 negative allosteric modulators (NAM) as potential novel treatment for levodopa-induced dyskinesia in Parkinson’s disease (PD-LID) and plan to initiate clinical studies in the near future.
20190927171733_5d8dd3ad12501
Glucokinase Activator(GKA) --- Dorzagliatin(HMS5552)is a first-in-class oral drug for the treatment of type 2 diabetes that under developed by Hua Medicine. Dorzagliatin has brand new mechanism and structure.
mGluR5 negative allosteric modulators (NAM) as potential novel treatment for levodopa-induced dyskinesia in Parkinson’s disease (PD-LID) and plan to initiate clinical studies in the near future.
l_a1_foue_back
Type 2 Diabetes Therapy

The Concept of Glucose Homeostasis

20191105111213_5dc0e88dd825f 20191107102919_5dc3817f3bbee
&
In Healthy Humans

Glucose concentrations for healthy individuals are maintained within a narrow range of 4-6.5mM --- glucose homeostasis, and regulated by various pathways. As the glucose sensor, glucokinase (GK) senses changes in glucose levels, which is essential for maintaining whole-body glucose homeostasis.

20191107102929_5dc381899eed8 20191107102939_5dc381938bdab
&
In Patients with Type 2 Diabetes

Impaired GK activity and function in T2D patients results in defects in glucose sensing, leading to disrupted glucose homeostasis.

20191107102949_5dc3819db5d0e 20191107102959_5dc381a72c7ca
&
Glucokinase Activator (GKA) Restores

A GKA can repair defective GK function and restore glucose homeostasis.

20191127124124_5dddfe743bbee
&
In Healthy Humans

Glucose concentrations for healthy individuals are maintained within a narrow range of 4-6.5mM --- glucose homeostasis, and regulated by various pathways. As the glucose sensor, glucokinase (GK) senses changes in glucose levels, which is essential for maintaining whole-body glucose homeostasis.

20191127124137_5dddfe81ef095
&
In Patients with Type 2 Diabetes

Impaired GK activity and function in T2D patients results in defects in glucose sensing, leading to disrupted glucose homeostasis.

20191127124154_5dddfe920df82
&
Glucokinase Activator (GKA) Restores

A GKA can repair defective GK function and restore glucose homeostasis.

l_a1_zjlq
GK
Activity
leo_lvdd leo_hongdd
Media
Focus Us
l_foot_lyixc
20191104104225_5dbf9011aa5f3
l_foot_wx
20190929160723_5d90663b11c8b
Copyright ? 2026  Hua Medicine (Shanghai) Ltd.    沪网药械信备字【2026】000123号
沪ICP备14036654号-1  beiantubiao.png 沪公网安备 31011502013809号  Privacy Statement  Terms of Use
l_foot_gotop
Search
l_ss_guanbi
How we use cookies
Hua Medicine uses cookies to enable and improve the use of the website. By continuing to use the site, you consent to the use of these cookies. To learn more about cookies, please read our privacy statement.
Accept
x

在天生打印内容,请稍后沉试。

【网站地图】